There are complex scenarios in which WES must be expanded to whole-genome sequencing (WGS)thus engaging with the remaining 98.5% of the genomewhen intronic regions of potential clinical relevance are suspectedfor instance, non-exonic pathogenic variants (Hiraide et al., 2022)
Semaglutide has become one of the most studied GLP-1 receptor agonists for weight loss, with clinical data showing participants lost 1522% of their body weight depending on the trial and dose protocol
At its peak, the company owned over 80 million square metres of facilities
Introduction Standing in front of a mirror with a vial and a syringe for the first time can feel overwhelming
NicheNet: modeling intercellular communication by linking ligands to target genes
A la doctora le preocupa que, al volverse cada vez ms popular, la gente asocie el frmaco con la vanidad y no lo identifique como un medicamento crucial para los pacientes diabticos